avapro and bilirubin
avapro has been researched along with bilirubin in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Biecker, E; Caselmann, WH; Heller, J; Hofer, U; Neef, M; Sauerbruch, T; Schepke, M; Schiedermaier, P; Stoffel-Wagner, B; Werner, E | 1 |
| Bakker, SJ; Cooper, ME; de Zeeuw, D; Deetman, PE; Lambers Heerspink, HJ; Lewis, JB; Navis, G; Riphagen, IJ | 1 |
| Agarwal, A; Hull, TD | 1 |
Trials
1 trial(s) available for avapro and bilirubin
| Article | Year |
|---|---|
Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension.
Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Bilirubin; Biphenyl Compounds; Double-Blind Method; Female; Humans; Hypertension, Portal; Hypotension; Irbesartan; Kidney Function Tests; Liver Circulation; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Renin; Tetrazoles | 2001 |
Other Studies
2 other study(ies) available for avapro and bilirubin
| Article | Year |
|---|---|
Bilirubin and progression of nephropathy in type 2 diabetes: a post hoc analysis of RENAAL with independent replication in IDNT.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Bilirubin; Biphenyl Compounds; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Irbesartan; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Retrospective Studies; Tetrazoles | 2014 |
Bilirubin: a potential biomarker and therapeutic target for diabetic nephropathy.
Topics: Bilirubin; Biphenyl Compounds; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Irbesartan; Losartan; Male; Tetrazoles | 2014 |